Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Living Tissue Engineered Skin Substitutes for Difficult to Heal Wounds
NCT02668042Phase 1Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2012
- Primary completion
- Dec 2015
01
Overview
Phase 1, randomised, open-label trial in Chronic wound, sponsored by Chinese PLA General Hospital. Primary endpoint: Frequency of Adverse Events at 6 months. Started Jan 2012; status: completed.
02
Conditions
Chronic wound
Beyond the preview
Go deeper on NCT02668042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668042.